Published on

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide


  1. 1. SEE WHO IS IN CHARGE OF THE DEADLY FIERCE VACCINE KILLER INFECTIOUS DISEASE VACCINES TARGETING NYC PUBLIC SCHOOL CHILDREN /story/merck-extends-idera-collaboration-hiv-vaccine- failures-point-future-success-adults-shun-flu--0#ixzz0QuDaT7Jw First New York City Mayor Bloomberg, Honorees Celebrate Laboratory Solely Devoted to the Development of an AIDS Vaccine Click here: New York City Mayor Bloomberg, Honorees Celebrate First Laboratory Solely Devoted to the Development of an AIDS Va 1. Seth Berkley - President and CEO, IAVI &query= BOYDEN+GRAY+Seth+Berkley&invocationType=tb50T B50CLab Thomas Campbell Jackson
  2. 2. ... M.D. PLASTIC SURGERY RESEARCH FOUNDATION C. BOYDEN GRAY, ESQ. ... Disease Control and Prevention, and Seth Berkley, MD, president of . ... - 30k - Similar pages 2. Dennis R. Burton - Scientific Director, IAVI Neutralizing Antibody Consortium and Professor, Department of Immunology, The Scripps Research Institute BURTON LABORATORY xx xx xx. xx xx. BURTON LABORATORY | THE SCRIPPS RESEARCH INSTITUTE | 10550 NORTH TORREY PINES ROAD | LA JOLLA | CALIFORNIA | 92037. - Cached - Similar - 3. Salim Abdool-Karim - Pro Vice Chancellor, University of KwaZulu- Natal, South Africa Salim S. Abdool Karim - Faculty Profile - Mailman School of Public ... Dr. Salim S. Abdool Karim is a clinical infectious diseases epidemiologist whose research interests are in microbicides and vaccines to prevent HIV ... www.mailman school .org/msphfacdir/profile.asp? uni=ssa16 - Cached - Similar -
  3. 3. New York - NIH Research Portfolio Online Reporting Tool (RePORT) ... CENTER Gray, Todd A 1R03AI053187-01 64535 Abdool Poxvirus/host interactions of the ...... SCIENCES Karim, Salim S 5D43TW000231-08 770441 PUBLIC HEALTH, .... And Cell Biology Regulation of Homeodomain Nuclear Translocation Boyden, ... t - Cached - Similar - Other Associated Projects - CAPRISA Salim Abdool Karim, Clive Gray and Scott Hammer are actively involved in the HVTN activities, including HVTN 040 as well as in various other committees ... - Cached - Similar - City (ZipCode): Organization PI Name Grant Number Amount Awarded ... ...Robert L R21NS044572-02 $185076 A Drosophila Model Of Batten Disease Gray, ...... SCIENCES Abdoolkarim, Salim S In D43TW000231-09 $692040 Public Health, .... Periodontal Diseases Boyden, Penelope A R01HL066140-03 $480334 Medicine, ...
  4. 4. grants. - Similar - Professor Salim Safurdeen "Slim" ABDOOL- KARIM (Profile) Who's Who ... Full names, Professor Salim Safurdeen "Slim" ABDOOL-KARIM. Synopsis, Chair: Department of Reproductive Health & Research WHO, Geneva; Director: Centre for ... - Cached - Similar - "ID","FirstName","MiddleName","LastName","Suffix","FullNam e ... Dept of Pathology","81 Highland Ave","Salem","MA","01970","Professional","Physician" ...... 581,"Karim"," ","Alavi","","Karim Alavi",,"UMass Memorial Medical ...... ","Baker","","Frederic Baker",,"52 Boyden Road","Suite# 202","Holden","MA" ... Harold Baker",,"Mass Gen Hosp Gray Bigelow 4","55 Fruit Street","Boston" ... - Cached - Similar -
  5. 5. 864612- CIATheWorldFactbookGovernmentData.kmz - Google Earth ... Ambassador C. Chief of mission: Boyden GRAY ... Vice Presidents Ahmad Zia MASOOD and Abdul Karim KHALILI (since 7 December 2004); ...... Chief of mission: Ambassador SALIM Abdallah al-Jabir al- Sabah ...... Sir Anerood JUGNAUTH (since 7 October 2003); Vice President Abdool Raouf BUNDHUN (since 25 February 2002) ... - Similar - Kompass - Dubai / United Arab Emirates / Worldwide Company Directory Abdul Rahim Abdul Karim Trading Co. .... Gray Business Communications · Planet Hollywood ..... Boyden Middle East · Gyma Enterprises FZE · Q M I Middle East ...... Al Kaen Equipment & Industrial Supplies (L.L.C) · Cube Graphics · Jassim Al Abdool Auto Spare Parts Trading (L.L.C) ...... Ali Bin Salim Contracting Co. ... - Cached - Similar - _____________________________________________________________________________ ____ New York City Mayor Bloomberg and Other Honorees Celebrate Opening of the First Laboratory Solely Devoted to the Development of an AIDS Vaccine celebrate-first-laboratory-solely-devoted-deve The International AIDS Vaccine Initiative Opens State-of-the-Art AIDS Vaccine Lab at Historic Brooklyn Army Terminal
  6. 6. November 10, 2008--(BUSINESS WIRE)--The International AIDS Vaccine Initiative WHAT: The International AIDS Vaccine Initiative (IAVI) opens a Vaccine Design and Development Laboratory in New York City, the only facility in the world exclusively devoted to the development of an AIDS vaccine. IAVI will be the first occupant of a planned new bioscience center, spearheaded by the City and State of New York and private entities, in the landmark Brooklyn Army Terminal in Sunset Park, Brooklyn. Scientists at IAVI's AIDS Vaccine Design and Development Lab, together with partners in academia, the private sector and government, will design, compare, prioritize and advance promising AIDS vaccine strategies, with the ultimate goal of ending the AIDS epidemic through an effective vaccine, accessible to all. New York City Mayor Michael Bloomberg and other distinguished guests will speak at a ribbon-cutting ceremony to celebrate the Design Lab's opening. WHO: Michael R. Bloomberg - Mayor, The City of New York Seth Berkley - President and CEO, IAVI Dennis R. Burton - Scientific Director, IAVI Neutralizing Antibody Consortium and Professor, Department of Immunology, The Scripps Research Institute Salim Abdool-Karim - Pro Vice Chancellor, University of KwaZulu-Natal, South Africa WHY: New York is a global city, and there are few global problems more pressing than AIDS. Despite advances made in AIDS treatment and some success with HIV prevention, AIDS
  7. 7. remains the number four killer globally and the number one in sub-Saharan Africa. Scientists agree that the best hope for ending the AIDS pandemic is through a preventive vaccine. New York City has the highest concentration of academic institutions in the world and is home to more than 125 bioscience companies, nine world-class medical centers and two of the four major global vaccine developers. All of which makes New York an ideal wellspring pioneering ideas for the kind of that will be necessary for development of an effective AIDS vaccine. WHERE: Brooklyn Army Terminal, 140 58th Street, Brooklyn NY 11220 WHEN: Wednesday, November 12 from 6:00PM to 9:00PM Media are invited to tour the facility and shoot B-roll footage earlier in the day from 12:00 - 1:30PM. More stories about Vaccines HIV/AIDS Read more: bloomberg-honorees-celebrate-first-laboratory-solely-devoted-deve#ixzz0RFEre4TU _____________________________________________________________________________ __________ COMPREHENSIVE WEB SITES:
  8. 8. 18 USC 1117 MULTIPLE CONSPIRACIES TO MURDER SWINE FLU VACCINE MASS MURDER/INFESTATION PLAN REGIONAL KILLER BOYDEN GRAY NAME ALIGNED MASS KILLING FIERCE VACCINES http://www. /story/merck-extends- idera-collaboration-hiv-vaccine-failures-point-future-success-adults-shun- flu--0#ixzz0QuDaT7Jw NEW FIERCE VACCINE REPUBLICAN NAME ALIGNMENTS: ______________________________________________________________________________ __________ National Children’s Study Begins Recruiting Volunteers The National Institutes of Health announced today that the National Children’s Study will begin recruiting volunteers to take part in its comprehensive study of how genes and the environment interact to affect children’s health. The study will track the health and development of more than 100,000 children from before birth through to their 21st birthday.
  9. 9. At a briefing, NIH officials announced that the first phase of recruitment for the study will begin in Duplin County, N.C., and the New York City borough of Queens.
  10. 10. Some 16,000 African children are being recruited for a clinical trial of a new malaria vaccine. probably going to "This is be one of the largest studies in infants and in children in Africa." says Joe Cohen, a vaccine researcher at GlaxoSmithKline. Story Vical says it has completed enrollment of subjects in a Phase II trial of its therapeutic DNA vaccine designed to prevent cytomegalovirus reactivation and disease in immunosuppressed stem cell transplant recipients. Release http://www. /story/merck-extends-idera-collaboration-hiv- vaccine-failures-point-future-success-adults-shun-flu--0#ixzz0QuDaT7Jw AND COMPREHENSIVE WEB SITES